Related Experiment Video
Updated: Jul 13, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Towards Outcome-Driven Patient Subgroups: A Machine Learning Analysis Across Six Depression Treatment Studies
David Benrimoh1, Akiva Kleinerman2, Toshi A Furukawa3
1Department of Psychiatry (DB, KP, GT), McGill University, Montreal, Canada; Department of Psychiatry (DB), Stanford University, Stanford, CA; Aifred Health (DB, CA, JM, RF, KP, SI, CP, GG, SQ, AA, MTS), Montreal, Canada.
Machine learning can identify patient profiles for major depressive disorder (MDD) treatment. This approach enhances treatment prediction and precision medicine for depression, improving clinical outcomes.
Area of Science:
- Neuroscience
- Computational Psychiatry
- Clinical Psychology
Background:
- Major Depressive Disorder (MDD) is complex with varied treatment responses.
- Predicting treatment outcomes in MDD remains challenging.
- Clinical interpretability of machine learning (ML) models for MDD is limited.
Purpose of the Study:
- To develop interpretable ML models for predicting treatment response in MDD.
- To derive patient profiles using clinical and demographic data.
- To enhance precision medicine approaches for MDD.
Main Methods:
- Analyzed data from 5438 participants across six depression treatment trials.
- Utilized the Differential Prototypes Neural Network (DPNN) ML model.
- Trained a model to predict remission probabilities for various treatments based on patient data.
Main Results:
- A 3-prototype ML model achieved an AUC of 0.66.
- Identified three distinct patient clusters with differential treatment responses.
- Cluster A: younger, severe symptoms, fatigue. Cluster B: older, less severe symptoms, high remission. Cluster C: severe symptoms, agitation, suicidal ideation, somatic symptoms.
Conclusions:
- Novel, interpretable patient profiles can be generated using ML.
- This approach can improve the interpretability of ML models in clinical settings.
- Enhanced ML interpretability holds potential for advancing precision medicine in MDD.
More Related Videos
07:12Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018